Myomaker Bio secures £325k to accelerate drug testing with lab-grown human muscle
Professor Mark Lewis, Myomaker Bio’s CEO, said: “It is extremely satisfying to see this outcome
after many years of work in this area alongside our incredible team. For our investors to believe in us
and our technologies is humbling and gratifying.